COMMUNIQUÉS West-GlobeNewswire

I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market
17/10/2018
MONTREAL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Quidel [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
17/10/2018
FIT Biotech Oy Company release October 17, 2018 at 06:15 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA
17/10/2018
SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural [...]
PCI Biotech: Exercise of employee share options, mandatory noticifation of trade and resolution to increase share capital
17/10/2018
Oslo (Norway), 17 October 2018 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. Options exercised and [...]
ASLAN Pharmaceuticals Enrolls First Subject in Phase 1 Study for ASLAN004 in Atopic Dermatitis
17/10/2018
SINGAPORE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT, Nasdaq: ASLN), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan [...]
SPINEWAY : Marketing of new Mont-Blanc Evo product line authorized in the United States
17/10/2018
Press release Ecully, October 17 2018 Marketing of new Mont-Blanc Evo product line authorized in the United States Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column ( [...]
SPINEWAY : Distribution de la gamme Mont-Blanc Evo autorisée aux Etats-Unis
17/10/2018
Communiqué de presse Ecully, le 17 octobre 2018 Distribution de la gamme Mont-Blanc Evo autorisée aux Etats-Unis Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la [...]
Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis
17/10/2018
Press release Results support move to registration studies, broadening Company’s clinical pipeline and reinforcing manufacturing and commercial momentum Gosselies, Belgium, 17 October 2018, 6 pm CEST – BONE THERAPEUTICS [...]
MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery -- UPDATE
17/10/2018
Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 (GLOBE NEWSWIRE) -- [...]
North Bud Farms Announces Creation of “1017” Distribution and Signing of a Letter of Intent to Acquire Cannabis Accessory Distributor and Product Developer Janey’s
17/10/2018
TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) ("NORTHBUD" or the "Company") announces the creation of “1017” distribution and signing of a letter of intent to acquire Ontario cannabis store [...]
GEn1E Lifesciences Granted Exclusive Option to License University of Maryland, Baltimore’s Selective P38 Kinase Inhibitor
17/10/2018
Access to University of Maryland, Baltimore’s broadly applicable P38 Kinase inhibitor technology offers GEn1E the potential to enter the clinic with an acute lung injury/acute respiratory distress syndrome therapy PALO [...]
HMS Holdings Corp. To Report Third Quarter 2018 Financial and Operating Results
17/10/2018
IRVING, Texas, Oct. 17, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report third quarter 2018 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, November 2, 2018 [...]
The Governance Institute Releases Strategy Toolbook to Support Hospital Leaders in Managing Two-Sided Risk Contracts
17/10/2018
New resource offers health system executives and boards tips on how to prepare for and succeed in two-sided risk arrangements LINCOLN, Neb., Oct. 17, 2018 (GLOBE NEWSWIRE) -- The Governance Institute, a service of NRC [...]
Canada House’s Abba Medix Corp. announces the launch of www.abbamedixgenetics.com to support seed sales to Canadian LPs
17/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV) is proud to [...]
Adverum Biotechnologies Announces Data Presented at the European Society of Gene and Cell Therapy (ESGCT)
17/10/2018
A single intravitreal injection of ADVM-022 in non-human primates (NHP) demonstrated durable expression of aflibercept sustained out to 22 months In an NHP model, ADVM-022 provided ocular expression of aflibercept at [...]
Rexahn Announces $7.5 Million Registered Direct Offering
17/10/2018
ROCKVILLE, Md., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced it has entered into definitive agreements with institutional investors to purchase approximately 5.77 [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05%
17/10/2018
BUENA, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update
17/10/2018
STOUGHTON, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, November 8, 2018 at 4:30 [...]
Albireo Granted Orphan Drug Designation For Lead Product Candidate A4250 for Treatment of Alagille Syndrome
17/10/2018
BOSTON, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]

Pages